The estimated Net Worth of Sandra Patterson is at least $2.98 Milion dollars as of 10 September 2024. Sandra Patterson owns over 901 units of Gilead Sciences stock worth over $2,984,824 and over the last 2 years Sandra sold GILD stock worth over $0.
Sandra has made over 9 trades of the Gilead Sciences stock since 2023, according to the Form 4 filled with the SEC. Most recently Sandra exercised 901 units of GILD stock worth $72,927 on 10 September 2024.
The largest trade Sandra's ever made was exercising 4,484 units of Gilead Sciences stock on 10 August 2023 worth over $362,935. On average, Sandra trades about 1,902 units every 61 days since 2023. As of 10 September 2024 Sandra still owns at least 36,877 units of Gilead Sciences stock.
You can see the complete history of Sandra Patterson stock trades at the bottom of the page.
Sandra's mailing address filed with the SEC is GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger a John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: